Curcumin inhibits metastatic progression of breast cancer cell through suppression of urokinase-type plasminogen activator by NF-kappa B signaling pathways

Molecular Biology Reports

Volumn 39, Issue 4, 2012, Pages 4803-4808

  Zong, Hong ^a   Wang, Feng ^a   Fan, Qing Xia ^a   Wang, Liu Xing ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

Author keywords

Breast cancer cell; Curcumin; Metastatic progression; NF kappa B; UPA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; UROKINASE; DNA;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CELL ADHESION; CELL ASSAY; CELL STRAIN MCF 7; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME RELEASE; ENZYME REPRESSION; HUMAN; HUMAN CELL; METASTASIS; METASTASIS INHIBITION; PROTEIN DNA BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; BREAST TUMOR; CELL SURVIVAL; DISEASE COURSE; FEMALE; METABOLISM; PATHOLOGY; PROTEIN BINDING; TUMOR CELL LINE;

CURCUMA LONGA;

BREAST NEOPLASMS; CELL ADHESION; CELL LINE, TUMOR; CELL SURVIVAL; CURCUMIN; DISEASE PROGRESSION; DNA, NEOPLASM; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NF-KAPPA B; PROTEIN BINDING; SIGNAL TRANSDUCTION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84863009779     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1273-5     Document Type: Article

References (28)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ (2009) Cancer statistics, 2009. CA Cancer J Clin 59:225-249
2. Jovanovic J, Roønneberg JA, Tost J, Kristensen V (2010) The epigenetics of breast cancer. Mol Oncol 4:242-254
3. Wickerham DL (2010) Breast cancer chemoprevention: Progress and controversy. Surg Oncol Clin N Am 19:463-473
4. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV (2008) Curcumin: From ancient medicine to current clinical trials. Cell Mol Life Sci 65:1631-1652
5. Kawamori T, Lubet R, Steele VE, Kelloff GJ, Kaskey RB, Rao CV, Reddy BS (1999) Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res 59:597-601
6. Shi M, Cai Q, Yao L, Mao Y, Ming Y, Ouyang G (2006) Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells. Cell Biol Int 30:221-226
7. Johnson SM, Gulhati P, Arrieta I, Wang X, Uchida T, Gao T, Evers BM (2009) Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling. Anticancer Res 29:3185-3190
8. Kim SY, Jung SH, Kim HS (2005) Curcumin is a potent broad spectrum inhibitor of matrix metalloproteinase gene expression in human astroglioma cells. Biochem Biophys Res Commun 337: 510-516
9. Kunnumakkara AB, Anand P, Aggarwal BB (2008) Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett 269:199-225
10. Mukhopadhyay A, Banerjee S, Stafford LJ, Xia C, Liu M, Aggarwal BB (2002) Curcumin-induced suppression of cell proliferation correlates with down-regulation of cyclin D1 expression and CDK4-mediated retinoblastoma protein phosphorylation. Oncogene 21:8852-8861
11. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112:3-25
12. Roy R, Yang J, Moses MA (2009) Matrix metalloproteinases as novel biomarkers and potential therapeutic targets in human cancer. J Clin Oncol 27:5287-5297
13. Raghu H, Sodadasu PK, Malla RR, Gondi CS, Estes N, Rao JS (2010) Localization of uPAR and MMP-9 in lipid rafts is critical for migration, invasion and angiogenesis in human breast cancer cells. BMC Cancer 10:647
14. Mazar AP, Henkin J, Goldfarb RH (1999) The urokinase plasminogen activator system in cancer: Implications for tumor angiogenesis and metastasis. Angiogenesis 3:15-32
15. Chandrasekar N, Mohanam S, Gujrati M, Olivero WC, Dinh DH, Rao JS (2003) Downregulation of uPA inhibits migration and PI3k/Akt signaling in glioblastoma cells. Oncogene 22:392-400
16. Huang S, Pettaway CA, Uehara H, Bucana CD, Fidler IJ (2001) Blockade of NF-jB 12 activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20:4188-4197
17. Siwak DR, Shishodia S, Aggarwal BB, Kurzrock R (2005) Curcumin-induced antiproliferative and proapoptotic effects in melanoma cells are associated with suppression of the InB kinase and nuclear factor jB activity and are independent of the B-raf/Mitogen activated/extracellular signal-regulated protein kinase pathway and the AKT pathway. Cancer 104:879-890
18. Cai XZ, Wang J, Li XD, Wang GL, Liu FN, Cheng MS, Li F (2009) Curcumin suppresses proliferation and invasion in human gastric cancer cells by downregulation of PAK1 activity and cyclin D1 expression. Cancer Biol Ther 8:1360-1368
19. Aravindan N, Madhusoodhanan R, Ahmad S, Johnson D, Herman TS (2008) Curcumin inhibits NFkappaB mediated radioprotection and modulate apoptosis related genes in human neuroblastoma cells. Cancer Biol Ther 7:569-576
20. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92:827-839
21. Andreasen PA, Egelund R, Petersen HH (2000) The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci 57:25-40
22. Crowley CW, Cohen RL, Lucas BK, Liu G, Shuman MA, Levinson AD (1993) Prevention of metastasis by inhibition of the urokinase receptor. Proc Natl Acad Sci USA 90:5021-5025
23. Andreasen PA, Kjoøller L, Christensen L, Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 72:1-22
24. Ossowski L, Aguirre-Ghiso JA (2000) Urokinase receptor and integrin partnership: 13 coordination of signaling for cell adhesion, migration and growth. Curr Opin Cell Biol 12:613-620
25. Yebra M, Goretzki L, Pfeifer M, Mueller BM (1999) Urokinasetype plasminogen activator binding to its receptor stimulates tumor cell migration by enhancing integrin-mediated signal transduction. Exp Cell Res 250:231-240
26. Sandur SK, Deorukhkar A, Pandey MK, Pabon AM, Shentu S, Guha S, Aggarwal BB, Krishnan S (2009) Curcumin modulates the radiosensitivity of colorectal cancer cells by suppressing constitutive and inducible NF kappaB activity. Int J Radiat Oncol Biol Phys 75:534-542
27. Hartojo W, Silvers AL, Thomas DG, Seder CW, Lin L, Rao H, Wang Z, Greenson JK, Giordano TJ, Orringer MB, Rehemtulla A, Bhojani MS, Beer DG, Chang AC (2010) Curcumin promotes apoptosis, increases chemosensitivity, and inhibits nuclear factor kappaB in esophageal adenocarcinoma. Transl Oncol 3:99-108
28. Cheng JC, Chou CH, Kuo ML, Hsieh CY (2006) Radiationenhanced hepatocellular carcinoma cell invasion with MMP-9 expression through PI3K/Akt/NF-kappaB signal transduction pathway. Oncogene 25:7009-7018